Stephen Tafor, MD
Interventional Pain Medicine · Macon, GANPI 1700844321
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,414 of the $16,082 with a category attached, or 71.0%. 29 manufacturers reported payments, led by Medtronic at 30.5% of the total. Reporting peaked in 2023 at $5,723 and has fallen 68.0% since, to $1,831 in 2025.
Across 376 payments — averaging $42.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Boston Scientific$5K
- Curonix LLC$2K
- Nalu Medical, Inc.$976
- Nevro Corp.$929
- Surgentec$610
- plus $2K from 23 others
What the payments were for
- Travel & lodging$4,61629%
- Food & beverage$11,41471%
- Education$520%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 82 | $4,912 |
| Boston Scientific | 114 | $4,564 |
| Curonix LLC | 13 | $1,634 |
| Nalu Medical, Inc. | 14 | $976 |
| Nevro Corp. | 25 | $929 |
| Surgentec | 1 | $610 |
| Collegium Pharmaceutical, Inc. | 34 | $495 |
| Vertos Medical, Inc. | 5 | $368 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $254 |
| Abbott | 20 | $227 |
| Scilex Pharmaceuticals Inc. | 10 | $203 |
| SPR Therapeutics, Inc | 3 | $145 |
| Flowonix Medical Incorporated | 2 | $125 |
| Redhill Biopharma Inc. | 6 | $110 |
| Biodelivery Sciences International, Inc. | 6 | $88 |
| Pfizer | 6 | $75 |
| Globus Medical | 3 | $54 |
| AstraZeneca | 3 | $45 |
| GRT US Holding, Inc. | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 3 | $37 |
| Forte Bio-pharma LLC | 2 | $35 |
| Shionogi Inc | 2 | $31 |
| MDD US Operations, LLC | 1 | $20 |
| Amgen | 1 | $20 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
| Orthogenrx Inc. | 1 | $18 |
| Painteq LLC | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Elutia, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$1,632
- INTELLIS ADAPTIVESTIM$1,504
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$1,319
- TiLink, Ion$610
- Nalu Neurostimulation System$527
- GENERAL PAIN MANAGEMENT$506
- Intracept$499
- Superion Indirect Decompression System$268
- WaveWriter Alpha Prime 16$218
- mild Device Kit$210
- G4 RF Generator$146
- Senza Spinal Cord Stimulation System$135
- Senza$122
- KYPHON EXPRESS II KYPHOPAK TRAY$120
- INTELLIS$104
How this compares
$16,082 in reported general payments places this provider in the 85th percentile of 129 interventional pain medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,370 | $61,507 |
| BelbucaBuprenorphine Hcl | 67 | $45,898 |
| Nucynta ErTapentadol Hcl | 26 | $31,279 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 639 | $19,203 |
| OxycontinOxycodone Hcl | 26 | $18,153 |
| Buprenorphine | 62 | $17,100 |
| ZtlidoLidocaine | 16 | $10,289 |
| Oxycodone Hcl | 323 | $6,845 |
| Morphine Sulfate ErMorphine Sulfate | 151 | $4,203 |
| Fentanyl | 43 | $4,045 |
| Lidocaine | 15 | $1,978 |
| Gabapentin | 121 | $1,261 |
| Pregabalin | 53 | $1,143 |
| Morphine Sulfate | 37 | $956 |
| Tramadol Hcl ErTramadol Hcl | 13 | $748 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Nucynta Er | $495 | $77,17793 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $203 | $10,28916 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 129 interventional pain medicine providers in Georgia.
Other interventional pain medicine in Macon
- Sandeep DattaMacon$28K
- Margaret BoltjaMacon$7K
- Jeremy PrineMacon$7K
- Emmanuel GageBrunswick$602K
- Jordan TateJasper$540K
- Christopher BovinetBrunswick$338K
- David RosenfeldCovington$249K
- Nathan NeufeldNewnan$171K
- Ryan BudwanyLawrenceville$123K
- Alexandra MoreiraAtlanta$79K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.